UniProt ID | SHC4_HUMAN | |
---|---|---|
UniProt AC | Q6S5L8 | |
Protein Name | SHC-transforming protein 4 | |
Gene Name | SHC4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 630 | |
Subcellular Localization | Cell junction, synapse, postsynaptic cell membrane. Colocalized with MUSK at the neuromuscular junction.. | |
Protein Description | Activates both Ras-dependent and Ras-independent migratory pathways in melanomas. Contributes to the early phases of agrin-induced tyrosine phosphorylation of CHRNB1.. | |
Protein Sequence | MRERGQDSLAGLVLYVGLFGHPGMLHRAKYSRFRNESITSLDEGSSGGSVGNKGSPQPPHPALAPHLPTEDATLPSQESPTPLCTLIPRMASMKLANPATLLSLKNFCLGTKEVPRLKLQESRDPGSSGPSSPETSLSRSGTAPPPQQDLVGHRATALTPDSCPLPGPGEPTLRSRQDRHFLQHLLGMGMNYCVRYMGCVEVLQSMRSLDFGMRTQVTREAISRLCEAVPGANGAIKKRKPPVKFLSTVLGKSNLQFSGMNIKLTISTCSLTLMNLDNQQIIANHHMQSISFASGGDPDTTDYVAYVAKDPVNQRACHILECHNGMAQDVISTIGQAFELRFKQYLKNPSLNTSCESEEVHIDSHAEEREDHEYYNEIPGKQPPVGGVSDMRIKVQATEQMAYCPIQCEKLCYLPGNSKCSSVYENCLEQSRAIGNVHPRGVQSQRDTSLLKHTCRVDLFDDPCYINTQALQSTPGSAGNQRSAQPLGSPWHCGKAPETVQPGATAQPASSHSLPHIKQQLWSEECYHGKLSRKAAESLLVKDGDFLVRESATSPGQYVLSGLQGGQAKHLLLVDPEGKVRTKDHVFDNVGHLIRYHMDNSLPIISSGSEVSLKQPVRKDNNPALLHSNK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Phosphorylation | MRERGQDSLAGLVLY CCCCCHHCHHHHHHH | 16.54 | - | |
15 | Phosphorylation | SLAGLVLYVGLFGHP CHHHHHHHHHHHCCC | 5.74 | - | |
37 | Phosphorylation | YSRFRNESITSLDEG HHHHCCCCCCCCCCC | 34.41 | 29507054 | |
39 | Phosphorylation | RFRNESITSLDEGSS HHCCCCCCCCCCCCC | 32.30 | 28348404 | |
40 | Phosphorylation | FRNESITSLDEGSSG HCCCCCCCCCCCCCC | 31.95 | 22617229 | |
100 | Phosphorylation | MKLANPATLLSLKNF CCCCCHHHHHHHCHH | 29.50 | 24114839 | |
103 | Phosphorylation | ANPATLLSLKNFCLG CCHHHHHHHCHHHHC | 40.17 | 24505115 | |
127 | Phosphorylation | QESRDPGSSGPSSPE CCCCCCCCCCCCCCC | 37.19 | 25850435 | |
128 | Phosphorylation | ESRDPGSSGPSSPET CCCCCCCCCCCCCCC | 61.71 | 25850435 | |
131 | Phosphorylation | DPGSSGPSSPETSLS CCCCCCCCCCCCCCC | 63.15 | 25850435 | |
132 | Phosphorylation | PGSSGPSSPETSLSR CCCCCCCCCCCCCCC | 29.86 | 29507054 | |
135 | Phosphorylation | SGPSSPETSLSRSGT CCCCCCCCCCCCCCC | 38.05 | 25850435 | |
136 | Phosphorylation | GPSSPETSLSRSGTA CCCCCCCCCCCCCCC | 23.76 | 25850435 | |
159 | Phosphorylation | GHRATALTPDSCPLP CCCCEEECCCCCCCC | 23.68 | - | |
196 | Phosphorylation | GMNYCVRYMGCVEVL CHHHHHHHHHHHHHH | 4.21 | 26503892 | |
218 | Phosphorylation | FGMRTQVTREAISRL CCCCHHHHHHHHHHH | 16.99 | 26503892 | |
374 | Phosphorylation | EEREDHEYYNEIPGK HHHCCHHHHHCCCCC | 14.26 | 22817900 | |
375 | Phosphorylation | EREDHEYYNEIPGKQ HHCCHHHHHCCCCCC | 11.88 | 22817900 | |
403 | Phosphorylation | QATEQMAYCPIQCEK EEECCCCCCCCCEEE | 8.07 | - | |
413 | Phosphorylation | IQCEKLCYLPGNSKC CCEEEEEECCCCCCC | 26.77 | - | |
424 | Phosphorylation | NSKCSSVYENCLEQS CCCCCHHHHHHHHHH | 11.90 | 25884760 | |
448 | Phosphorylation | GVQSQRDTSLLKHTC CCCCHHHHHHHHCCC | 24.38 | - | |
449 | Phosphorylation | VQSQRDTSLLKHTCR CCCHHHHHHHHCCCE | 35.67 | 24719451 | |
465 | Phosphorylation | DLFDDPCYINTQALQ ECCCCCCEECHHHHH | 11.55 | 28152594 | |
468 | Phosphorylation | DDPCYINTQALQSTP CCCCEECHHHHHCCC | 12.98 | 28152594 | |
473 | Phosphorylation | INTQALQSTPGSAGN ECHHHHHCCCCCCCC | 37.10 | - | |
489 | Phosphorylation | RSAQPLGSPWHCGKA CCCCCCCCCCCCCCC | 32.28 | 28555341 | |
505 | Phosphorylation | ETVQPGATAQPASSH CCCCCCCCCCCCCCC | 31.57 | 27251275 | |
510 | Phosphorylation | GATAQPASSHSLPHI CCCCCCCCCCCCHHH | 34.95 | 27251275 | |
511 | Phosphorylation | ATAQPASSHSLPHIK CCCCCCCCCCCHHHH | 21.14 | 27251275 | |
513 | Phosphorylation | AQPASSHSLPHIKQQ CCCCCCCCCHHHHHH | 45.61 | 27251275 | |
523 | Phosphorylation | HIKQQLWSEECYHGK HHHHHHHCCHHHCCH | 31.91 | 26270265 | |
527 | Phosphorylation | QLWSEECYHGKLSRK HHHCCHHHCCHHCHH | 19.52 | 26270265 | |
532 | Phosphorylation | ECYHGKLSRKAAESL HHHCCHHCHHHHHHH | 34.91 | 26270265 | |
534 | Acetylation | YHGKLSRKAAESLLV HCCHHCHHHHHHHEE | 48.88 | 8082881 | |
538 | Phosphorylation | LSRKAAESLLVKDGD HCHHHHHHHEECCCC | 23.44 | - | |
542 | Acetylation | AAESLLVKDGDFLVR HHHHHEECCCCEEEE | 56.83 | 8082891 | |
569 | Acetylation | GLQGGQAKHLLLVDP CCCCCCCEEEEEECC | 27.22 | 8082901 | |
596 | Phosphorylation | NVGHLIRYHMDNSLP CHHHHHHHHCCCCCC | 8.42 | - | |
601 | Phosphorylation | IRYHMDNSLPIISSG HHHHCCCCCCEECCC | 31.12 | 27251275 | |
606 | Phosphorylation | DNSLPIISSGSEVSL CCCCCEECCCCCEEC | 29.39 | - | |
609 | Phosphorylation | LPIISSGSEVSLKQP CCEECCCCCEECCCC | 36.45 | - | |
612 | Phosphorylation | ISSGSEVSLKQPVRK ECCCCCEECCCCCCC | 26.29 | - | |
628 | Phosphorylation | NNPALLHSNK----- CCCCCCCCCC----- | 46.41 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
159 | T | Phosphorylation | Kinase | ERK2 | P28482 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SHC4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SHC4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
EGFR_HUMAN | EGFR | physical | 24430869 | |
GRB2_HUMAN | GRB2 | physical | 24430869 | |
NBEA_HUMAN | NBEA | physical | 28514442 | |
GARE1_HUMAN | GAREM | physical | 28514442 | |
IKKA_HUMAN | CHUK | physical | 28514442 | |
DCAM_HUMAN | AMD1 | physical | 28514442 | |
SHC3_HUMAN | SHC3 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...